Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to stop caregiver burnout with Short-Term support

NCT ID NCT07496996

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 16, 2026 · Updated 5 times

Summary

This study will test whether a 4-week stay in a dedicated transitional care unit can help people with disabilities and their primary caregivers avoid breakdowns and exhaustion. Researchers will track whether each patient meets their personal goal set at admission. The study involves 100 participants and aims to improve care pathways and reduce emergency visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that a short stay in a specialized unit helps people with disabilities and their caregivers avoid crises and reduce emergency care.
What could go wrong
This is a small, early-stage study with no control group, so results may not apply broadly. It only measures goal achievement, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients: * People with disabilities requiring a 4-week stay in a dedicated transitional care unit at POLE MPR ST HELIER * Men or women, of legal age (over 18) * Affiliated with a social security scheme or entitled to benefits * Having given their free and informed consent * Caregivers: * Primary caregiver from the circle of a person with a disability who has agreed to participate in the study. * Male or female, of legal age (over 18) * Affiliated with a social security scheme or entitled to benefits * Having given their free and informed consent Exclusion Criteria: * Patients: * Pregnant women, women in labor, or women who are breastfeeding * Individuals deprived of their liberty by judicial (excluding guardianship or curatorship) or administrative decision * Individuals undergoing severe psychiatric treatment that may impact the conduct of the protocol, at the investigator's discretion * Individuals in an emergency situation who are unable to give their prior consent. * Caregivers: * Professional caregivers of participants with disabilities who have agreed to participate in the study. * Pregnant women, women in labor, or women who are breastfeeding, * Individuals deprived of their liberty by a judicial (excluding guardianship or curatorship) or administrative decision. * Individuals undergoing severe psychiatric treatment that may impact the conduct of the protocol, at the investigator's discretion * Individuals in an emergency situation who are unable to give their prior consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Caregiver are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fondation Saint-Hélier

    RECRUITING

    Rennes, 35043, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.